Impossible Foods

Focuses on investing in disruptive and technology-focused start-ups. Founded in 1999.

Privately owned hedge fund founded in 1999 investing across different sectors.

Founded by the tennis legend Serena Williams as an investment vehicle to empower historically overlooked people and markets.

Broadly, a venture we back offers one or more of the factors: 1. Significant technology or business model innovation 2. “Black Swan” ideas with significant upside or a significantly better mousetrap 3. Large markets, either existing or newly enabled by the innovation at hand 4. Short innovation cycles 5. Upfront risk

Serena Williams is an American professional tennis player who is currently ranked No. 1 in women's singles tennis. Williams is also the reigning French Open, US Open, WTA Tour Championships and Olympic ladies singles champion. In 2008, Williams helped to fund the construction of the Serena Williams Secondary School in Matooni, Kenya. She received a Celebrity Role Model Award from Avon Foundation in 2003 for work in breast cancer. Williams has also been involved in a number of clinics at schools and community centers, particularly those which have programs focusing on at-risk youth; she has also won the "Young Heroes Award" from Big Brothers Big Sisters of Greater L.A. and Inland (2003) and the "Family Circle and Prudential Financial Player Who Makes a Difference Award" (2004).

Co-chair of the Bill & Melinda Gates Foundation. Founder of Breakthrough Energy. Co-founder of Microsoft.

A tech founder, builder, and investor. He’s written a national bestselling book, Without Their Permission, and co-founded initialized capital and Reddit. In 2020, Alexis founded Seven Seven Six, a new software-enabled venture firm focused on people, culture, and community.

Samir focuses on health, sustainability, food, and advanced technology investments. Samir led the firm’s investments in Cadre, Guardant Health (NASDAQ: GH), Impossible Foods, Mojo Vision, NanoH2O (acquired by LG Chem), Nutanix (NASDAQ: NTNX), Oscar, Quantumscape, and Ultima,among others. Prior to co-founding Khosla Ventures, Samir spent five years at Flagship Ventures where he started and invested in early-stage biotechnology companies. While there, he was involved in co-founding Helicos BioSciences (IPO), a leader in developing single-molecule sequencing instruments to revolutionize personalized medicine, along with Stan Lapidus and Steve Quake of Stanford. Samir was also founding CEO of Codon Devices, where he raised their Series A financing, built the technical and advisory teams, and booked significant revenues in the company’s first year of operations. His other investments include Epitome (acquired by Millipore), LS9 (acquired by REG), and Morphotek (acquired by Eisai).